ARCHIVES

ASCO Annual Meeting: PARP Inhibitors Show Promise Against Breast Cancer In Small Phase II Studies

This article is from The Cancer Letter archive.

Vol. 35 No. 22 | June 5, 2009

Download PDF Visit The Full Archive

Related Articles

Weight An Indicator For Risk Of Developing Myeloma

August 31, 2007

Six Institutions Get Awards For LAK-IL-2 Trials

February 7, 1986

NCI Remains Exception To NIH Authority Over Scientific Counselors

January 27, 1995

Cancer Documentary Provides Argument for Increased Funding

May 23, 1986

Letter: Legal Fund Seeks Support For Fisher

March 3, 1995

Clinton Declares Month of April Cancer Control Month

April 11, 1997